Accuray Incorporated

Madison – October 31, 2026 -- Accuray Incorporated (NASDAQ: ARAY) granted 650,000 restricted stock units and 650,000 performance-based restricted stock units (at target) to Sofiane Laoussadi, its new Senior Vice President, Global Services & Solutions. The two awards cover 1.3 million shares of common stock at target.

Awards fall under NASDAQ inducement rule 5635(c)(4)

The Compensation Committee approved the grants as a material inducement for Laoussadi to join the company, in line with NASDAQ Listing Rule 5635(c)(4). Accuray disclosed them as that rule requires. Both awards took effect on October 30, 2026.

The grants sit outside the company's current equity plan. Their terms are generally consistent with those of the 2026 Equity Incentive Plan.

Madison, Wis. – September 27, 2026 -- Accuray Incorporated (NASDAQ: ARAY) has signed agreements with Samsung HME America's NeuroLogica Corp. unit to pursue advanced volumetric imaging capabilities for its CyberKnife System, the companies announced at the ASTRO Annual Meeting in Boston.

Samsung's mobile CT expertise meets Accuray's robotic radiosurgery platform

The collaboration pairs Samsung NeuroLogica's mobile computed tomography and volumetric imaging technology with Accuray's precision treatment delivery, robotic radiosurgery and motion-management systems. No commercial product has been announced; the partnership will proceed through phased technical, clinical and commercial evaluation subject to regulatory requirements.

Madison, Wis. – September 17, 2026 -- Accuray Incorporated (NASDAQ: ARAY) and RaySearch Laboratories AB (publ) have signed a definitive agreement expanding their collaboration to accelerate adoption of online adaptive radiation therapy, with Accuray committing to purchase RayStation software licenses valued at $8 million.

Accuray commits $8 million to RaySearch software licenses

Under the deal, Accuray will buy specified RayStation licenses to support commercialization of online adaptive radiation therapy solutions, which both companies will jointly market and support. The agreement also brings RaySearch's RayCare technology into the partnership to simplify connectivity between clinical systems and streamline adaptive workflows.